Skip to content

LivaNova LIVN Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Haemonetics logo
HaemoneticsHAE
Medtronic logo
MedtronicMDT
ITG
Integer HoldingsITGR
ResMed logo
ResMedRMD
Boston Scientific logo
Boston ScientificBSX
Stryker logo
StrykerSYK

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's software and technology licenses, net?
LivaNova (LIVN) reported software and technology licenses, net of $15.37M in Q1 2026.
How has LivaNova's software and technology licenses, net changed year-over-year?
LivaNova's software and technology licenses, net increased by 10.7% year-over-year, from $13.88M to $15.37M.
What is the long-term trend for LivaNova's software and technology licenses, net?
Over 5 years (2020 to 2025), LivaNova's software and technology licenses, net has grown at a 6.9% compound annual growth rate (CAGR), from $11.25M to $15.69M.